EP3350183 - SOLID FORMS OF ISOQUINOLINONE DERIVATIVES, PROCESS OF MAKING, COMPOSITIONS COMPRISING, AND METHODS OF USING THE SAME [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 23.06.2020 Database last updated on 12.07.2024 | |
Former | Request for examination was made Status updated on 22.06.2018 | ||
Former | The international publication has been made Status updated on 25.03.2017 | ||
Former | unknown Status updated on 07.11.2016 | Most recent event Tooltip | 16.02.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states Infinity Pharmaceuticals, Inc. 780 Memorial Drive Cambridge, MA 02139 / US | [2018/30] | Inventor(s) | 01 /
GRENIER, Louis 140 Sargent Street Newton, MA 02458 / US | 02 /
LESCARBEAU, Andre 99 Porter Street Somerville, MA 02143 / US | 03 /
SHARMA, Praveen 16 Christine Road Arlington, MA 02474 / US | 04 /
GENOV, Daniel G. 1155 Jones Street, Apartment 303 San Francisco, CA 94109 / US | [N/P] |
Former [2018/30] | 01 /
GRENIER, Louis 140 Sargent Street Newton, MA 02458 / US | ||
02 /
LESCARBEAU, Andre 99 Porter Street Somerville, MA 02143 / US | |||
03 /
SHARMA, Praveen 16 Christine Road Arlington, MA 02474 / US | |||
04 /
GENOV, Daniel G. 160 Commonwealth Avenue Apt 706 Boston, MA 02116 / US | Representative(s) | Abel & Imray LLP Westpoint Building James Street West Bath BA1 2DA / GB | [N/P] |
Former [2018/30] | Abel & Imray Westpoint Building James Street West Bath BA1 2DA / GB | Application number, filing date | 16766827.6 | 13.09.2016 | [2018/30] | WO2016US51490 | Priority number, date | US201562218493P | 14.09.2015 Original published format: US 201562218493 P | US201562218486P | 14.09.2015 Original published format: US 201562218486 P | [2018/30] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017048702 | Date: | 23.03.2017 | Language: | EN | [2017/12] | Type: | A1 Application with search report | No.: | EP3350183 | Date: | 25.07.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.03.2017 takes the place of the publication of the European patent application. | [2018/30] | Search report(s) | International search report - published on: | EP | 23.03.2017 | Classification | IPC: | C07D487/04, A61K31/519, A61P35/00 | [2018/30] | CPC: |
C07D487/04 (EP,CN,IL,KR,US);
A61K31/519 (EP,IL,KR,US);
A61K9/485 (KR,US);
A61K9/4858 (KR,US);
A61K9/4866 (KR,US);
A61P29/00 (EP,CN);
A61P35/00 (EP,CN,KR);
A61P37/02 (CN);
A61P37/06 (EP);
A61P43/00 (EP);
C07D231/12 (EP,US);
C07D231/38 (EP,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/30] | Title | German: | FESTE FORMEN VON ISOCHINOLINONDERIVATEN, HERSTELLUNGSVERFAHREN, ZUSAMMENSETZUNGEN DAMIT UND VERWENDUNGSVERFAHREN DAFÜR | [2018/30] | English: | SOLID FORMS OF ISOQUINOLINONE DERIVATIVES, PROCESS OF MAKING, COMPOSITIONS COMPRISING, AND METHODS OF USING THE SAME | [2018/30] | French: | FORMES SOLIDES DE DÉRIVÉS D'ISOQUINOLINONE, LEUR PROCÉDÉ DE FABRICATION, COMPOSITIONS LES COMPRENANT ET MÉTHODES D'UTILISATION DE CELLES-CI | [2018/30] | Entry into regional phase | 14.03.2018 | National basic fee paid | 14.03.2018 | Designation fee(s) paid | 14.03.2018 | Examination fee paid | Examination procedure | 14.03.2018 | Examination requested [2018/30] | 14.03.2018 | Date on which the examining division has become responsible | 12.11.2018 | Amendment by applicant (claims and/or description) | 26.06.2020 | Despatch of a communication from the examining division (Time limit: M06) | 05.01.2021 | Reply to a communication from the examining division | 14.12.2021 | Despatch of a communication from the examining division (Time limit: M06) | 15.06.2022 | Reply to a communication from the examining division | 08.08.2023 | Despatch of a communication from the examining division (Time limit: M06) | 16.02.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 01.04.2018 | Renewal fee patent year 03 | 13.09.2019 | Renewal fee patent year 04 | 14.09.2020 | Renewal fee patent year 05 | 15.09.2021 | Renewal fee patent year 06 | 11.08.2022 | Renewal fee patent year 07 | 24.08.2023 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [IY]WO2015051244 (INFINITY PHARMACEUTICALS INC [US]); | [YA]WO2015051241 (INFINITY PHARMACEUTICALS INC [US]) |